Mark Stejbach insider trades

Open-market stock purchases and sales by Mark Stejbach, Director at Indivior Pharmaceuticals, Inc, from SEC Form 4 filings since Apr 9, 2010.

Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +77%.

Recent trades

DateStockTradeValue
May 13, 2026INDV Indivior Pharmaceuticals, IncBought (not open market)—
Jan 26, 2026INDV Indivior Pharmaceuticals, IncBought (not open market)—
Jan 5, 2026INDV Indivior plcBought$27.4K

Companies traded

  • INDV Indivior Pharmaceuticals, Inc: 1 buy, last May 13, 2026
  • FLXN Flexion Therapeutics Inc: 2 buys, last Nov 19, 2021
  • ALKS Alkermes plc.: 1 buy, 12 sales, last Mar 3, 2018
  • TNGN Tengion Inc: 1 buy, last May 11, 2011

Get free alerts when Mark Stejbach files a new trade →